Related Experiment Video
Updated: Dec 27, 2025

Author Spotlight: Studying Macrophage-Epithelial Cell Interactions in Salivary Gland Regeneration After Injury
Published on: November 17, 2023
Modulation of Monocyte-Driven Myositis in Alphavirus Infection Reveals a Role for CX3CR1+ Macrophages in Tissue
Ali Zaid1,2,3, Kothila Tharmarajah4,2,3, Helen Mostafavi4,2,3
1Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia a.zaid@griffith.edu.au s.mahalingam@griffith.edu.au.
Abstract:
Arthritogenic alphaviruses such as Ross River and Chikungunya viruses cause debilitating muscle and joint pain and pose significant challenges in the light of recent outbreaks. How host immune responses are orchestrated after alphaviral infections and lead to musculoskeletal inflammation remains poorly understood. Here, we show that myositis induced by Ross River virus (RRV) infection is driven by CD11bhi Ly6Chi inflammatory monocytes and followed by the establishment of a CD11bhi Ly6Clo CX3CR1+ macrophage population in the muscle upon recovery. Selective modulation of CD11bhi Ly6Chi monocyte migration to infected muscle using immune-modifying microparticles (IMP) reduced disease score, tissue damage, and inflammation and promoted the accumulation of CX3CR1+ macrophages, enhancing recovery and resolution. Here, we detail the role of immune pathology, describing a poorly characterized muscle macrophage subset as part of the dynamics of alphavirus-induced myositis and tissue recovery and identify IMP as an effective immunomodulatory approach. Given the lack of specific treatments available for alphavirus-induced pathologies, this study highlights a therapeutic potential for simple immune modulation by IMP in infected individuals in the event of large alphavirus outbreaks.IMPORTANCE Arthritogenic alphaviruses cause debilitating inflammatory disease, and current therapies are restricted to palliative approaches. Here, we show that following monocyte-driven muscle inflammation, tissue recovery is associated with the accumulation of CX3CR1+ macrophages in the muscle. Modulating inflammatory monocyte infiltration using immune-modifying microparticles (IMP) reduced tissue damage and inflammation and enhanced the formation of tissue repair-associated CX3CR1+ macrophages in the muscle. This shows that modulating key effectors of viral inflammation using microparticles can alter the outcome of disease by facilitating the accumulation of macrophage subsets associated with tissue repair.
Insights
Immune-modifying microparticles (IMP) reduced muscle damage and inflammation from Ross River virus infection by modulating inflammatory monocytes and promoting tissue repair macrophages.
Area of Science:
- Immunology
- Virology
- Pathology
Background:
- Arthritogenic alphaviruses like Ross River virus (RRV) cause severe muscle and joint pain, with immune responses poorly understood.
- Current treatments for alphavirus-induced inflammation are limited to palliative care.
Purpose of the Study:
- To elucidate the host immune response dynamics during alphavirus-induced myositis.
- To investigate the therapeutic potential of immune-modifying microparticles (IMP) in alphavirus infection.
Main Methods:
- Induction of myositis in a mouse model using Ross River virus (RRV).
- Characterization of immune cell populations, specifically monocytes and macrophages, in infected muscle.
- Administration of immune-modifying microparticles (IMP) to modulate monocyte migration.
- Assessment of disease severity, tissue damage, inflammation, and immune cell accumulation.
Main Results:
- RRV-induced myositis was driven by CD11bhi Ly6Chi inflammatory monocytes.
- Recovery was associated with the accumulation of CD11bhi Ly6Clo CX3CR1+ macrophages in the muscle.
- IMP treatment reduced disease scores, tissue damage, and inflammation.
- IMP promoted the accumulation of CX3CR1+ macrophages, enhancing tissue recovery.
Conclusions:
- Muscle macrophage subsets play a critical role in alphavirus-induced myositis and subsequent tissue repair.
- IMP represent a promising immunomodulatory strategy to mitigate alphavirus-induced inflammation and promote recovery.
- Targeting key immune cell effectors with microparticles can shift disease outcomes towards tissue repair.

